Tongue ultrasound for children and teens with obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort of children and adolescents (6–18 years) with obesity who undergo standardized submental ultrasound at baseline and after a 30-week inpatient multidisciplinary weight-loss rehabilitation program. Ultrasound measures include tongue morphology, fat-related imaging biomarkers, and mechanical properties using shear-wave elastography. Anthropometric data and validated sleep-disordered breathing questionnaires are collected in parallel, and measurement reliability is tested. The study explores associations between ultrasound parameters, body measurements, and obstructive sleep apnea outcomes over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children and adolescents aged 6 to 18 years
* Diagnosis of obesity
* Already enrolled in the inpatient weight-loss rehabilitation program at the Zeepreventorium
* Written informed consent from legal guardian and assent from the participant, following the legal requirements

Exclusion Criteria:

* Known orthopedic, traumatic, or rheumatologic conditions affecting the cervicocephalic region
* Contraindication to ultrasound examination
* Inability to comply with study procedures
* Inability to understand the procedures

Where it's running

• ISEK-HE2B, av. Schalle 91
  Brussels, Belgium Recruiting
• Zeepreventorium Koninklijke Baan 5
  De Haan, Belgium Not yet recruiting

Study contacts

• Study coordinator: Frederic Paillaugue, MSc PT
• Email: frederic.paillaugue@vub.be
• Phone: +32485952930

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How incretin treatments affect muscle mass and function in people with overweight or obesity

  This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

  Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

• Dose find for remimazolam plus alfentanil for gastroscopy in obese adults

  This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07925684

• Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults

  This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.

  Recruiting Yuzuncu Yil University · Van · NCT07901777

• Gut barrier and inflammation after fast-food overfeeding in adults

  This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.

  Recruiting University Hospital, Gentofte, Copenhagen · Hellerup · NCT07893743

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• GLP-1 weight‑loss medicine: finding who will benefit most

  This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.

  Recruiting Phase 4 Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07870538

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.